Search Results - "Skandsen, T."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Incidence of hospital-admitted severe traumatic brain injury and in-hospital fatality in Norway: a national cohort study by Andelic, N, Anke, A, Skandsen, T, Sigurdardottir, S, Sandhaug, M, Ader, T, Roe, C

    Published in Neuroepidemiology (01-01-2012)
    “…The aims of this study were to assess the incidence of hospital-admitted severe traumatic brain injury (TBI) in the adult population in Norway, and to…”
    Get more information
    Journal Article
  2. 2

    White matter microstructure in chronic moderate-to-severe traumatic brain injury: Impact of acute-phase injury-related variables and associations with outcome measures by Håberg, A.K., Olsen, A., Moen, K.G., Schirmer-Mikalsen, K., Visser, E., Finnanger, T.G., Evensen, K.A.I., Skandsen, T., Vik, A., Eikenes, L.

    Published in Journal of neuroscience research (01-07-2015)
    “…This study examines how injury mechanisms and early neuroimaging and clinical measures impact white matter (WM) fractional anisotropy (FA), mean diffusivity…”
    Get full text
    Journal Article
  3. 3

    Intensive care and traumatic brain injury after the introduction of a treatment protocol: a prospective study by SCHIRMER-MIKALSEN, K., MOEN, K. G., SKANDSEN, T., VIK, A., KLEPSTAD, P.

    Published in Acta anaesthesiologica Scandinavica (01-01-2013)
    “…Background Traumatic brain injury (TBI) treatment protocols have been introduced in the intensive care unit (ICU) to avoid secondary brain injury. In this…”
    Get full text
    Journal Article
  4. 4

    Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit by Schirmer-Mikalsen, K., Vik, A., Gisvold, S. E., Skandsen, T., Hynne, H., Klepstad, P.

    Published in Acta anaesthesiologica Scandinavica (01-10-2007)
    “…Background:  In patients with severe head injury, control of physiological variables is important to avoid intracranial hypertension and secondary injury to…”
    Get full text
    Journal Article
  5. 5

    A33 Traumatic brain injury: treatment and extracranial complications in the intensive care unit after the introduction of a treatment protocol by Schirmer-Mikalsen, K, Vik, A, Skandsen, T, Moen, K.G, Klepstad, P

    Published in European journal of anaesthesiology (01-02-2012)
    “…BACKGROUND:In 2003 we introduced a standardized treatment protocol for patients with traumatic brain injury (TBI) treated in the intensive care unit (ICU). The…”
    Get full text
    Journal Article
  6. 6

    Neuroacanthocytosis - the variability of presenting symptoms in two siblings by Aasly, J., Skandsen, T., Rø, M.

    Published in Acta neurologica Scandinavica (01-11-1999)
    “…Neuroacanthocytosis is a progressive multisystem disease with a wide range of symptoms. The involuntary movements mainly include chorea and orofaciolingual…”
    Get full text
    Journal Article
  7. 7

    B-63 Subacute Cognitive Sequelae of Mild Traumatic Brain Injury on the Cambridge Neuropsychological Test Automated Battery (CANTAB) and Traditional Neuropsychological Tests by Stenberg, J, Karlsen, R, Saksvik, S, Iverson, G, Karr, J, Vik, A, Skandsen, T

    Published in Archives of clinical neuropsychology (28-08-2019)
    “…Abstract Objective This study examined cognitive functioning at approximately two weeks following mild traumatic brain injury (MTBI) and explored whether tests…”
    Get full text
    Journal Article
  8. 8

    One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury by Clarke, Gerard Janez Brett, Skandsen, Toril, Zetterberg, Henrik, Einarsen, Cathrine Elisabeth, Feyling, Casper, Follestad, Turid, Vik, Anne, Blennow, Kaj, Håberg, Asta Kristine

    Published in Frontiers in neurology (21-04-2021)
    “…To investigate the longitudinal evolution of three blood biomarkers: neurofilament light (NFL), glial fibrillary acidic protein (GFAP) and tau, in out-patients…”
    Get full text
    Journal Article
  9. 9

    Health-related quality of life 12 months after severe traumatic brain injury: a prospective nationwide cohort study by Soberg, Helene L, Røe, Cecilie, Anke, Audny, Arango-Lasprilla, Juan Carlos, Skandsen, Toril, Sveen, Unni, von Steinbüchel, Nicole, Andelic, Nada

    Published in Journal of rehabilitation medicine (01-09-2013)
    “…To assess health-related quality of life in individuals with severe traumatic brain injury at 12 months post-injury, applying the Quality of Life after Brain…”
    Get full text
    Journal Article
  10. 10

    Improvement in Functional Outcome from 6 to 12 Months After Moderate and Severe Traumatic Brain Injury Is Frequent, But May Not Be Detected With the Glasgow Outcome Scale Extended by Pantelatos, Rabea Iris, Stenberg, Jonas, Follestad, Turid, Sandrød, Oddrun, Einarsen, Cathrine Elisabeth, Vik, Anne, Skandsen, Toril

    Published in Neurotrauma reports (01-02-2024)
    “…The aims of this study were (1) to report outcome and change in outcome in patients with moderate and severe traumatic brain injury (mo/sTBI) between 6 and 12…”
    Get full text
    Journal Article
  11. 11

    Severe traumatic brain injury in Norway: impact of age on outcome by Roe, Cecilie, Skandsen, Toril, Anke, Audny, Ader, Tiina, Vik, Anne, Lund, Stine Borgen, Mannskow, Unn, Sollid, Snorre, Sundstrøm, Terje, Hestnes, Morten, Andelic, Nada

    “…The aim of this study was to investigate the influence of age on mortality and 3-month outcome in a Norwegian cohort of patients with severe traumatic brain…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Transforming growth factor-beta 1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines by Helseth, E, Dalen, A, Unsgaard, G, Skandsen, T, Grøndahl-Hansen, J, Lund, L R

    “…Transforming growth factor-beta 1 has been shown to suppress the urokinase activity in the glioblastoma cell line T-MG1 and the carcinoma cell line T-CAR1. The…”
    Get more information
    Journal Article
  14. 14

    Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines by Georg, B, Helseth, E, Lund, L R, Skandsen, T, Riccio, A, Danø, K, Unsgaard, G, Andreasen, P A

    Published in Molecular and cellular endocrinology (01-01-1989)
    “…Tumor necrosis factor-alpha (TNF-alpha) was found to induce type-1 plasminogen activator inhibitor (PAI-1) antigen in the human fibrosarcoma cell line HT-1080,…”
    Get more information
    Journal Article
  15. 15

    Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours by Helseth, E, Unsgaard, G, Dalen, A, Fure, H, Skandsen, T, Odegaard, A, Vik, R

    Published in British journal of neurosurgery (1988)
    “…Amplification and overexpression of proto-oncogenes are associated with the malignant nature of some human tumours. In this study we have determined the…”
    Get more information
    Journal Article
  16. 16